Speciality
Spotlight

       




 


Medicine


   

 




Transfusion
Medicine

  

  • G
    Barosi, M Marchetti, NL Liberato (IRCCS Policlinico
    S -Matteo, Pavia, Italy)

    Cost-effectiveness of Recombinant Human Erythropoietin in the Prevention
    of Chemotherapy-induced Anaemia
    .

    Br.
    J Cancer  78:781-787,
    1998
    .

     

    As it is currently used, rHuEPO is not
    cost-effective for the treatment of
    chemotherapy-induced anaemia.

      

 



 

           

Speciality Spotlight

       

 
Medicine
   

 

Transfusion Medicine
  

  • G Barosi, M Marchetti, NL Liberato (IRCCS Policlinico S -Matteo, Pavia, Italy)
    Cost-effectiveness of Recombinant Human Erythropoietin in the Prevention of Chemotherapy-induced Anaemia.
    Br. J Cancer  78:781-787, 1998.
     
    As it is currently used, rHuEPO is not cost-effective for the treatment of chemotherapy-induced anaemia.
      

 

 

By |2022-07-20T16:41:59+00:00July 20, 2022|Uncategorized|Comments Off on Transfusion Medicine

About the Author: